Sign In

Daniel Grosu

President & CEO at PetDx

Daniel S. Grosu is a prominent figure in the field of veterinary diagnostics, serving as the Founder, President, and CEO of PetDx, a San Diego-based company specializing in liquid biopsy technology for dogs. He established PetDx in 2019, motivated by personal experiences with cancer in his family and his pet dog, Poppy, who passed away from pancreatic cancer at a young age. This experience inspired him to leverage his extensive background in genomics and healthcare to improve cancer detection in pets.15

Educational Background and Professional Experience

Grosu holds an MD with Distinction in Research from Saint Louis University and an MBA from the University of Oxford. His career spans various roles in the human diagnostics sector, including significant positions at Illumina and Sequenom. At Illumina, he was the first Chief Medical Officer, where he played a crucial role in developing next-generation sequencing technologies. He later served as CMO at Sequenom, focusing on non-invasive prenatal testing and liquid biopsy applications for cancer.15

Contributions to PetDx

Under Grosu's leadership, PetDx has developed its flagship product, OncoK9, a multi-cancer early detection test that can identify up to 30 types of canine cancer through a simple blood draw. The company has raised substantial funding—over $72 million—supporting its mission to enhance veterinary care through advanced genomic analysis.123 The OncoK9 test represents a significant advancement in veterinary diagnostics, providing veterinarians with tools to detect cancer earlier and more accurately than traditional methods.26

Current Role

As of January 2023, Grosu transitioned from his role as CEO to serve as Chairman of the Board, while Alejandro Bernal took over as CEO. Grosu continues to influence the strategic direction of PetDx and remains actively involved in biotechnology investments.45

In addition to his professional pursuits, Grosu is known for his passion for scuba diving and exploring marine environments globally.5

Highlights

Feb 9 · cbinsights.com
PetDx - Products, Competitors, Financials, Employees ... - CB Insights
Jan 25 · dvm360.com
PetDx names new president and chief executive officer - DVM360
May 3 · decibio.com
Cancer Detection in Dogs: OncoK9 Liquid Biopsy and the CANDiD ...
Cancer Detection in Dogs: OncoK9 Liquid Biopsy and the CANDiD ...
Feb 2 · geniusvets.com
Daniel S. Grosu, MD, MBA - GeniusVets

Related Questions

What inspired Daniel Grosu to transition from human diagnostics to veterinary cancer detection?
How did Daniel Grosu's experience at Illumina influence the development of OncoK9?
What are the key challenges Daniel Grosu has faced in establishing PetDx?
How does OncoK9 compare to other cancer detection methods in humans?
What future developments is PetDx planning in the field of veterinary cancer diagnostics?
Daniel Grosu
Daniel Grosu, photo 1
Daniel Grosu, photo 2
Add to my network

Location

San Diego, California, United States